Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Schizophrenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00102479
What this trial is testing

Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and Adolescents

Who this might be right for
SchizophreniaMania
Otsuka Pharmaceutical Development & Commercialization, Inc. 21
Post-approval studies (Phase 4)Study completedNCT00331825
What this trial is testing

Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism

Who this might be right for
SchizophreniaExtrapyramidal Syndrome
Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan 70
Testing effectiveness (Phase 2)Study completedNCT00694707
What this trial is testing

Safety and Efficacy of Cariprazine (RGH-188) in the Acute Exacerbation of Schizophrenia

Who this might be right for
Schizophrenia
Forest Laboratories 732
Large-scale testing (Phase 3)Study completedNCT03160521
What this trial is testing

Study to Evaluate the Efficacy and Safety of Risperidone in Situ Microparticle (ISM)® in Patients With Acute Schizophrenia

Who this might be right for
Acute Schizophrenia
Rovi Pharmaceuticals Laboratories 438
Large-scale testing (Phase 3)Ended earlyNCT01307800
What this trial is testing

LY2140023 in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Denovo Biopharma LLC 567
Not applicableUnknownNCT04215094
What this trial is testing

Early Diagnosis of Intracranial Infection After Craniotomy

Who this might be right for
Intracranial; Infection, Psychosis, Acute or Subacute
Pan Jun 500
Post-approval studies (Phase 4)Study completedNCT00644800
What this trial is testing

The Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of Psychosis

Who this might be right for
SchizophreniaManiaDelusional Disorder+1 more
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 89
Not applicableStudy completedNCT02192723
What this trial is testing

Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia

Who this might be right for
Schizophrenia
Beijing HuiLongGuan Hospital 550
Large-scale testing (Phase 3)Study completedNCT00645372
What this trial is testing

Compare the Efficacy and Safety of Ziprasidone and Risperidone for the Treatment of Schizophrenia in Chinese Patients

Who this might be right for
Schizophrenia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 242
Large-scale testing (Phase 3)Study completedNCT01541371
What this trial is testing

Flexibly Dosed Paliperidone Extended Release Tablets in Participants With Schizophrenia

Who this might be right for
Schizophrenia
Xian-Janssen Pharmaceutical Ltd. 405
Not applicableStudy completedNCT01232790
What this trial is testing

A Pilot Trial of Acute N-Acetylcysteine Effects on Working Memory and Other Cognitive Functions in Schizophrenia

Who this might be right for
Schizophrenia
Yale University 28
Testing effectiveness (Phase 2)Study completedNCT02477020
What this trial is testing

Efficacy and Safety Study of TAK-063 in Participants With an Acute Exacerbation of Schizophrenia

Who this might be right for
Schizophrenia
Takeda 164
Not applicableUnknownNCT04700930
What this trial is testing

CBD Cigarettes Instead of Normal Cigarettes as Innovative Treatment for Schizophrenia

Who this might be right for
Schizophrenia and Other Psychotic DisordersHarm Reduction
Psychiatric Hospital of the University of Basel 31
Testing effectiveness (Phase 2)Study completedNCT01490086
What this trial is testing

RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder

Who this might be right for
Acute SchizophreniaSchizoaffective Disorder
Reviva Pharmaceuticals 234
Testing effectiveness (Phase 2)WithdrawnNCT00988728
What this trial is testing

Efficacy & Safety of SCH 900435 in Schizophrenia (Study P06079)(WITHDRAWN)

Who this might be right for
Schizophrenia
Merck Sharp & Dohme LLC
Testing effectiveness (Phase 2)Study completedNCT07116694
What this trial is testing

Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder

Who this might be right for
Bipolar I DisorderBipolar II DisorderSchizophrenia+3 more
BioXcel Therapeutics Inc 33
Large-scale testing (Phase 3)Study completedNCT00882518
What this trial is testing

Efficacy and Safety of Quetiapine Fumarate in the Treatment of Schizophrenic Patients

Who this might be right for
Schizophrenia
AstraZeneca 388
Not applicableStudy completedNCT07673718
What this trial is testing

Α-N-acetylgalactosaminidase in Schizoaffective Disorder

Who this might be right for
Schizoaffective Disorder
Elazığ Mental Health and Diseases Hospital 93
Large-scale testing (Phase 3)Study completedNCT02634346
What this trial is testing

ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)

Who this might be right for
Schizophrenia
Alkermes, Inc. 403
Large-scale testing (Phase 3)Study completedNCT00299715
What this trial is testing

Evaluate the Efficacy and Safety of Three Fixed Doses of Extended-release Paliperidone in Subjects With Bipolar I Disorder

Who this might be right for
Bipolar DisorderMood Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 473
Next Page